Cash flow Neuronetics, Inc.

Equities

STIM

US64131A1051

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2025-06-20 pm EDT			5-day change	1st Jan Change
3.460 ^USD	+2.37%		-8.71%	+114.91%

Jun. 17	Neuronetics, Inc., Q1 2025 Earnings Call, May 06, 2025
Jun. 10	Neuronetics Announces Clinical Presence At The 2025 Clinical TMS Society Annual Meeting And Progress In Greenbrook's Personalized Care Trial Program	RE

7b280f7753a48945ea5ad.9EuhCOI2B1fCLyiShuezcXqo9xXmOftuYZG0ITlVzOc.wjnNPrZnSmWtVR3jzJfmFQPLokWFWrMLGKbWZ1wz_tWyBdh4h0BJL6BWXw

Published financial data: NEURONETICS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	49.24M	55.31M	65.21M	71.35M	74.89M
Total Revenues	49.24M	55.31M	65.21M	71.35M	74.89M
Cost of Goods Sold, Total	11.55M	11.65M	15.48M	17.74M	20.13M
Gross Profit	37.69M	43.66M	49.72M	53.6M	54.76M
Selling General & Admin Expenses, Total	49M	62.8M	74.9M	72.64M	75.95M
R&D Expenses	9.2M	7.92M	9.34M	9.52M	12.77M
Other Operating Expenses, Total	58.2M	70.72M	84.23M	82.16M	88.72M
Operating Income	-20.51M	-27.06M	-34.51M	-28.55M	-33.96M
Interest Expense, Total	-4.52M	-4.02M	-4.25M	-5.42M	-7.29M
Interest And Investment Income	302K	390K	2.2M	600K	500K
Net Interest Expenses	-4.22M	-3.63M	-2.05M	-4.82M	-6.79M
Other Non Operating Income (Expenses)	-	-	-	2.29M	-451K
EBT, Excl. Unusual Items	-24.73M	-30.69M	-36.56M	-31.09M	-41.2M
Asset Writedown	-	-	-	-2M	-600K
Other Unusual Items	-2.72M	-500K	-600K	2.9M	-1.93M
EBT, Incl. Unusual Items	-27.45M	-31.19M	-37.16M	-30.19M	-43.73M
Earnings From Continuing Operations	-27.45M	-31.19M	-37.16M	-30.19M	-43.73M
Net Income to Company	-27.45M	-31.19M	-37.16M	-30.19M	-43.73M
Minority Interest	-	-	-	-	19K
Net Income - (IS)	-27.45M	-31.19M	-37.16M	-30.19M	-43.71M
Net Income to Common Incl Extra Items	-27.45M	-31.19M	-37.16M	-30.19M	-43.71M
Net Income to Common Excl. Extra Items	-27.45M	-31.19M	-37.16M	-30.19M	-43.71M
Per Share Items
Net EPS - Basic	-1.46	-1.22	-1.38	-1.05	-1.38
Basic EPS - Continuing Operations	-1.46	-1.22	-1.38	-1.05	-1.38
Basic Weighted Average Shares Outstanding	18.84M	25.48M	26.9M	28.66M	31.73M
Net EPS - Diluted	-1.46	-1.22	-1.38	-1.05	-1.38
Diluted EPS - Continuing Operations	-1.46	-1.22	-1.38	-1.05	-1.38
Diluted Weighted Average Shares Outstanding	18.84M	25.48M	26.9M	28.66M	31.73M
Normalized Basic EPS	-0.82	-0.75	-0.85	-0.68	-0.81
Normalized Diluted EPS	-0.82	-0.75	-0.85	-0.68	-0.81
Supplemental Items
EBITDA	-19.57M	-26M	-32.86M	-26.64M	-31.98M
EBITA	-20.51M	-27.06M	-34.51M	-28.55M	-33.96M
EBIT	-20.51M	-27.06M	-34.51M	-28.55M	-33.96M
EBITDAR	-18.97M	-25.3M	-32.06M	-25.84M	-30.98M
Normalized Net Income	-15.46M	-19.18M	-22.85M	-19.43M	-25.73M
Interest on Long-Term Debt	4.52M	4.02M	4.25M	5.42M	7.29M
Supplemental Operating Expense Items
Selling and Marketing Expenses	32.56M	37.75M	49.98M	47.22M	45.63M
General and Administrative Expenses	16.44M	25.05M	24.92M	25.43M	30.32M
Research And Development Expense From Footnotes	9.2M	7.92M	9.34M	9.52M	12.77M
Net Rental Expense, Total	600K	700K	800K	800K	1M
Imputed Operating Lease Interest Expense	597K	578K	686K	679K	803K
Imputed Operating Lease Depreciation	2.55K	122K	114K	121K	197K
Stock-Based Comp., COGS (Total)	66K	79K	130K	140K	140K
Stock-Based Comp., R&D Exp. (Total)	449K	198K	462K	677K	644K
Stock-Based Comp., S&M Exp. (Total)	1.81M	2.1M	4.29M	2.33M	1.41M
Stock-Based Comp., G&A Exp. (Total)	2.08M	5.5M	3.87M	4.17M	3.41M
Total Stock-Based Compensation	4.4M	7.87M	8.75M	7.32M	5.6M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	48.96M	94.14M	70.34M	59.68M	18.46M
Total Cash And Short Term Investments	48.96M	94.14M	70.34M	59.68M	18.46M
Accounts Receivable, Total	9.05M	9.9M	15.13M	16.69M	23.56M
Other Receivables	-	-	-	2.9M	2.9M
Notes Receivable	-	74K	230K	2.06M	930K
Total Receivables	9.05M	9.98M	15.36M	21.64M	27.39M
Inventory	3.72M	6.56M	8.9M	8.09M	4.25M
Prepaid Expenses	2.19M	3.09M	2.17M	1.87M	3.95M
Restricted Cash	-	-	-	-	1M
Other Current Assets, Total	1.1M	1.56M	2M	2.51M	3.08M
Total Current Assets	65.01M	115M	98.77M	93.79M	58.12M
Gross Property Plant And Equipment	6.55M	7.64M	8.38M	7.6M	36.58M
Accumulated Depreciation	-2.4M	-2.54M	-3.06M	-2.82M	-3.24M
Net Property Plant And Equipment	4.15M	5.1M	5.32M	4.78M	33.34M
Goodwill	-	-	-	-	18.63M
Other Intangibles, Total	1.2M	-	3.6M	4.2M	20.01M
Accounts Receivable Long-Term	2.33M	1.7M	1.22M	661K	86K
Loans Receivable Long-Term	-	10.11M	362K	3.8M	295K
Deferred Charges Long-Term	5.3M	6.76M	7.57M	8.37M	8.9M
Other Long-Term Assets, Total	666K	2.22M	45K	230K	1.52M
Total Assets	78.66M	141M	117M	116M	141M
Liabilities
Accounts Payable, Total	3.75M	4.3M	2.43M	4.75M	11.08M
Accrued Expenses, Total	6.78M	7.93M	14.51M	12.38M	12.59M
Current Portion of Long-Term Debt	-	-	13.12M	-	-
Current Portion of Leases	594K	670K	824K	845K	4.79M
Unearned Revenue Current, Total	2.02M	2.5M	1.98M	1.62M	974K
Other Current Liabilities	536K	306K	328K	213K	1.84M
Total Current Liabilities	13.68M	15.7M	33.2M	19.81M	31.26M
Long-Term Debt	34.62M	35.34M	22.83M	59.28M	55.15M
Long-Term Leases	3.12M	3.54M	2.97M	2.35M	22.69M
Unearned Revenue Non Current	1.74M	1.47M	829K	200K	2K
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	53.16M	56.05M	59.82M	81.64M	109M
Preferred Stock Convertible	-	-	-	-	-
Preferred Stock - Others	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	191K	264K	273K	291K	557K
Additional Paid In Capital	303M	394M	403M	410M	447M
Retained Earnings	-278M	-309M	-346M	-376M	-420M
Total Common Equity	25.49M	85.18M	57.06M	34.19M	27.71M
Minority Interest	-	-	-	-	4.09M
Total Equity	25.49M	85.18M	57.06M	34.19M	31.8M
Total Liabilities And Equity	78.66M	141M	117M	116M	141M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	25.41M	26.63M	28.36M	29.76M	65.81M
ECS Total Common Shares Outstanding	19.11M	26.4M	27.27M	29.09M	55.68M
Book Value / Share	1.33	3.23	2.09	1.18	0.5
Tangible Book Value	24.29M	85.18M	53.46M	29.99M	-10.93M
Tangible Book Value Per Share	1.27	3.23	1.96	1.03	-0.2
Total Debt	38.34M	39.54M	39.74M	62.47M	82.63M
Net Debt	-10.62M	-54.6M	-30.6M	2.8M	64.17M
Debt Equivalent Oper. Leases	4.8M	5.6M	6.4M	6.4M	8M
Minority Interest, Total (Incl. Fin. Div)	-	-	-	-	4.09M
Account Code - Inventory Valuation	5	5	5	5	5
Machinery, Total	2.68M	3.29M	3.61M	2.85M	7.28M
Full Time Employees	126	175	194	203	716
Assets on Operating Lease - Gross	-	-	-	542K	598K
Assets on Operating Lease - Accumulated Depreciation	-	-	-	-42K	-298K
Accumulated Allowance for Doubtful Accounts (Supple)	1.01M	1.46M	1.65M	795K	1.93M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-27.45M	-31.19M	-37.16M	-30.19M	-43.71M
Depreciation & Amortization - CF	941K	1.06M	1.65M	2.01M	2.07M
Depreciation & Amortization, Total	941K	1.06M	1.65M	2.01M	2.07M
(Gain) Loss From Sale Of Asset	-	-	-	-	28K
Asset Writedown & Restructuring Costs	-	-	-	-	3.96M
Stock-Based Compensation (CF)	4.4M	7.87M	8.75M	7.32M	5.6M
Provision and Write-off of Bad Debts	-	-	-	390K	2.06M
Other Operating Activities, Total	1.99M	918K	801K	2.54M	5.8M
Change In Accounts Receivable	-597K	-3.05M	-6.32M	-8.83M	-3.73M
Change In Inventories	-945K	-3.44M	-2.59M	-1.1M	3.15M
Change In Accounts Payable	-1.08M	276K	-1.97M	2.03M	-1.98M
Change in Unearned Revenues	-573K	215K	-1.16M	-989K	-843K
Change in Other Net Operating Assets	-5.08M	-630K	7.26M	-5.21M	-3.4M
Cash from Operations	-28.39M	-27.98M	-30.74M	-32.04M	-31M
Capital Expenditure	-730K	-2.35M	-3.27M	-2.37M	-1.47M
Cash Acquisitions	-	-	-	-	-2.55M
Other Investing Activities, Total	-	-7.49M	10M	1.05M	1.61M
Cash from Investing	-730K	-9.84M	6.73M	-1.32M	-2.41M
Long-Term Debt Issued, Total	41.36M	-	-	25M	57.48M
Total Debt Issued	41.36M	-	-	25M	57.48M
Long-Term Debt Repaid, Total	-38.86M	-	-	-1.2M	-64.18M
Total Debt Repaid	-38.86M	-	-	-1.2M	-64.18M
Issuance of Common Stock	690K	83.41M	298K	1K	1K
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-821K	-401K	-91K	-1.1M	-103K
Cash from Financing	2.37M	83.01M	207K	22.7M	-6.81M
Net Change in Cash	-26.75M	45.18M	-23.8M	-10.66M	-40.22M
Supplemental Items
Cash Interest Paid	3.89M	3.3M	3.54M	4.79M	6.51M
Levered Free Cash Flow	-17.14M	-16.04M	-20.12M	-20.25M	-17.61M
Unlevered Free Cash Flow	-14.31M	-13.53M	-17.47M	-16.86M	-13.06M
Change In Net Working Capital	6.11M	3.19M	3.02M	5.97M	-1.96M
Net Debt Issued / Repaid	2.5M	-	-	23.8M	-6.71M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-14.34	-15.39	-16.71	-15.34	-16.54
Return on Total Capital	-17.56	-17.94	-19.47	-18.45	-20.11
Return On Equity %	-74.86	-56.37	-52.25	-66.17	-132.53
Return on Common Equity	-74.86	-56.37	-52.25	-66.17	-141.23
Margin Analysis
Gross Profit Margin %	76.54	78.93	76.26	75.13	73.12
SG&A Margin	99.5	113.54	114.86	101.82	101.42
EBITDA Margin %	-39.74	-47.01	-50.4	-37.34	-42.7
EBITA Margin %	-41.65	-48.93	-52.93	-40.02	-45.35
EBIT Margin %	-41.65	-48.93	-52.93	-40.02	-45.35
Income From Continuing Operations Margin %	-55.75	-56.39	-56.99	-42.31	-58.39
Net Income Margin %	-55.75	-56.39	-56.99	-42.31	-58.36
Net Avail. For Common Margin %	-55.75	-56.39	-56.99	-42.31	-58.36
Normalized Net Income Margin	-31.39	-34.68	-35.04	-27.23	-34.36
Levered Free Cash Flow Margin	-34.8	-29	-30.86	-28.38	-23.52
Unlevered Free Cash Flow Margin	-29.06	-24.46	-26.79	-23.63	-17.44
Asset Turnover
Asset Turnover	0.55	0.5	0.51	0.61	0.58
Fixed Assets Turnover	10.88	11.96	12.51	14.13	3.93
Receivables Turnover (Average Receivables)	5.97	5.84	5.21	4.49	3.72
Inventory Turnover (Average Inventory)	3.56	2.27	2	2.09	3.26
Short Term Liquidity
Current Ratio	4.75	7.34	2.98	4.73	1.86
Quick Ratio	4.24	6.63	2.57	4	1.44
Operating Cash Flow to Current Liabilities	-2.07	-1.78	-0.93	-1.62	-0.99
Days Sales Outstanding (Average Receivables)	61.32	62.55	70.06	81.38	98.35
Days Outstanding Inventory (Average Inventory)	102.87	161.04	182.25	174.78	112.2
Average Days Payable Outstanding	122.6	101.32	68.95	77.42	177.89
Cash Conversion Cycle (Average Days)	41.59	122.27	183.37	178.74	32.66
Long Term Solvency
Total Debt/Equity	150.37	46.43	69.65	182.73	259.84
Total Debt / Total Capital	60.06	31.71	41.06	64.63	72.21
LT Debt/Equity	148.04	45.64	45.21	180.25	244.78
Long-Term Debt / Total Capital	59.13	31.17	26.65	63.76	68.02
Total Liabilities / Total Assets	67.59	39.69	51.18	70.48	77.43
EBIT / Interest Expense	-4.54	-6.73	-8.12	-5.26	-4.66
EBITDA / Interest Expense	-4.19	-6.3	-7.54	-4.76	-4.25
(EBITDA - Capex) / Interest Expense	-4.36	-6.88	-8.31	-5.2	-4.45
Total Debt / EBITDA	-2.02	-1.56	-1.24	-2.42	-2.67
Net Debt / EBITDA	0.56	2.16	0.95	-0.11	-2.07
Total Debt / (EBITDA - Capex)	-1.95	-1.43	-1.12	-2.21	-2.55
Net Debt / (EBITDA - Capex)	0.54	1.97	0.87	-0.1	-1.98
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-21.41	12.32	17.89	9.42	4.96
Gross Profit, 1 Yr. Growth %	-20.26	15.84	13.89	7.81	2.16
EBITDA, 1 Yr. Growth %	-24.35	32.89	26.38	-20.63	19.6
EBITA, 1 Yr. Growth %	-23.84	31.96	27.52	-18.68	18.53
EBIT, 1 Yr. Growth %	-23.84	31.96	27.52	-18.68	18.53
Earnings From Cont. Operations, 1 Yr. Growth %	-5.48	13.62	19.13	-18.76	44.84
Net Income, 1 Yr. Growth %	-5.48	13.62	19.13	-18.76	44.78
Normalized Net Income, 1 Yr. Growth %	-14.86	24.12	19.11	-16.34	32
Diluted EPS Before Extra, 1 Yr. Growth %	-7.76	-16.01	12.83	-23.74	30.75
Accounts Receivable, 1 Yr. Growth %	21.53	9.4	52.76	10.3	41.19
Inventory, 1 Yr. Growth %	34.05	76.42	35.59	-9.06	-47.51
Net Property, Plant and Equip., 1 Yr. Growth %	-15.4	23.05	4.19	-10.08	597.09
Total Assets, 1 Yr. Growth %	-21.48	79.54	-17.23	-0.9	21.65
Tangible Book Value, 1 Yr. Growth %	-47.93	250.62	-35.34	-43.9	-136.46
Common Equity, 1 Yr. Growth %	-46.73	234.11	-33.01	-40.08	-18.96
Cash From Operations, 1 Yr. Growth %	-6.86	-1.43	9.85	4.23	-3.25
Capital Expenditures, 1 Yr. Growth %	-10.21	222.33	38.93	-27.53	-38.12
Levered Free Cash Flow, 1 Yr. Growth %	7.27	-6.4	25.45	-1.21	-13.3
Unlevered Free Cash Flow, 1 Yr. Growth %	4.67	-5.47	29.1	-5.5	-22.84
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-3.4	-6.04	15.07	13.57	7.17
Gross Profit, 2 Yr. CAGR %	-3.33	-3.89	14.86	10.81	4.94
EBITDA, 2 Yr. CAGR %	1.61	0.27	24.01	0.16	-2.39
EBITA, 2 Yr. CAGR %	1.69	0.25	24.38	1.78	-1.65
EBIT, 2 Yr. CAGR %	1.69	0.25	24.38	1.78	-1.65
Earnings From Cont. Operations, 2 Yr. CAGR %	6.74	3.63	16.34	-1.62	8.48
Net Income, 2 Yr. CAGR %	6.74	3.63	16.34	-1.62	8.45
Normalized Net Income, 2 Yr. CAGR %	1.3	2.8	17.39	-0.17	5.26
Diluted EPS Before Extra, 2 Yr. CAGR %	-26.43	-11.98	-2.65	-7.24	-0.15
Accounts Receivable, 2 Yr. CAGR %	26.92	15.31	29.27	29.8	24.79
Inventory, 2 Yr. CAGR %	23.68	53.79	54.67	11.05	-30.91
Net Property, Plant and Equip., 2 Yr. CAGR %	73.5	2.03	13.23	-3.21	150.37
Total Assets, 2 Yr. CAGR %	-18.01	18.74	21.9	-9.44	9.8
Tangible Book Value, 2 Yr. CAGR %	-41.11	35.12	48.35	-39.77	-54.78
Common Equity, 2 Yr. CAGR %	-40.1	33.42	49.61	-36.64	-30.32
Cash From Operations, 2 Yr. CAGR %	17.42	-4.19	4.05	7	0.42
Capital Expenditures, 2 Yr. CAGR %	-15.03	70.12	111.61	0.34	-33.03
Levered Free Cash Flow, 2 Yr. CAGR %	12.44	0.2	4.97	11.28	-7.31
Unlevered Free Cash Flow, 2 Yr. CAGR %	12.79	-0.53	6.37	10.37	-14.45
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	6.79	1.58	1.34	13.16	10.63
Gross Profit, 3 Yr. CAGR %	6.96	2.68	1.7	12.46	7.84
EBITDA, 3 Yr. CAGR %	14.57	11.12	8.31	7.62	6.39
EBITA, 3 Yr. CAGR %	14.65	10.92	8.62	8.57	7.21
EBIT, 3 Yr. CAGR %	14.65	10.92	8.62	8.57	7.21
Earnings From Cont. Operations, 3 Yr. CAGR %	19.57	8.98	8.56	3.22	11.92
Net Income, 3 Yr. CAGR %	19.57	8.98	8.56	3.22	11.9
Normalized Net Income, 3 Yr. CAGR %	15.48	8.4	7.97	5.43	9.69
Diluted EPS Before Extra, 3 Yr. CAGR %	-74.35	-23.11	-4.38	-10.26	4
Accounts Receivable, 3 Yr. CAGR %	28.5	20.79	26.64	22.61	33.49
Inventory, 3 Yr. CAGR %	14.66	39.22	47.47	29.58	-13.5
Net Property, Plant and Equip., 3 Yr. CAGR %	45.06	54.72	2.75	4.86	86.92
Total Assets, 3 Yr. CAGR %	26.41	6.47	5.28	13.77	-0.08
Tangible Book Value, 3 Yr. CAGR %	-49.89	6.74	4.65	7.28	-49.05
Common Equity, 3 Yr. CAGR %	-49.04	6.23	6.04	10.28	-31.23
Cash From Operations, 3 Yr. CAGR %	36.58	10.77	0.28	4.11	3.47
Capital Expenditures, 3 Yr. CAGR %	7.11	32.52	59.02	48.05	-14.59
Levered Free Cash Flow, 3 Yr. CAGR %	25.87	5.78	8	3.5	2.5
Unlevered Free Cash Flow, 3 Yr. CAGR %	27.91	6.34	8.5	2.99	-1.92
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	10.07	10.03	6.22	3.63
Gross Profit, 5 Yr. CAGR %	-	9.6	10.05	5.86	2.99
EBITDA, 5 Yr. CAGR %	-	24.58	20.36	7.05	4.34
EBITA, 5 Yr. CAGR %	-	23.72	20.46	7.56	4.75
EBIT, 5 Yr. CAGR %	-	23.72	20.46	7.56	4.75
Earnings From Cont. Operations, 5 Yr. CAGR %	-	22.66	18.27	4.61	8.53
Net Income, 5 Yr. CAGR %	-	22.66	18.27	4.61	8.52
Normalized Net Income, 5 Yr. CAGR %	-	22.26	17.88	5.23	7.23
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-56.31	-56.27	-17.12	-2.71
Accounts Receivable, 5 Yr. CAGR %	-	22.59	28.81	24.32	25.9
Inventory, 5 Yr. CAGR %	-	31.08	29.24	27.18	8.89
Net Property, Plant and Equip., 5 Yr. CAGR %	-	25.68	31.37	28.25	46.72
Total Assets, 5 Yr. CAGR %	-	41.61	24.59	-0.2	7.06
Tangible Book Value, 5 Yr. CAGR %	-	-13.62	-22.65	-15.6	-25.19
Common Equity, 5 Yr. CAGR %	-	-13.62	-21.6	-13.61	-10.35
Cash From Operations, 5 Yr. CAGR %	-	26.79	22.5	9.24	0.34
Capital Expenditures, 5 Yr. CAGR %	-	48.67	40.65	18.57	12.51
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	18.55	8.36	1.97
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	20.63	8.43	-0.92